Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Axsome Therapeutics (AXSM) Current Taxes: 2024-2025

Historic Current Taxes for Axsome Therapeutics (AXSM) over the last 1 years, with Mar 2025 value amounting to $960,000.

  • Axsome Therapeutics' Current Taxes rose 95.12% to $960,000 in Q1 2025 from the same period last year, while for Mar 2025 it was $960,000, marking a year-over-year increase of 95.12%. This contributed to the annual value of $960,000 for FY2024, which is N/A change from last year.
  • Latest data reveals that Axsome Therapeutics reported Current Taxes of $960,000 as of Q1 2025, which was down 0.00% from $960,000 recorded in Q4 2024.
  • Axsome Therapeutics' 5-year Current Taxes high stood at $960,000 for Q4 2024, and its period low was $492,000 during Q1 2024.
  • In the last 2 years, Axsome Therapeutics' Current Taxes had a median value of $493,000 in 2024 and averaged $679,600.
  • Data for Axsome Therapeutics' Current Taxes shows a peak YoY soared of 95.12% (in 2025) over the last 5 years.
  • Over the past 2 years, Axsome Therapeutics' Current Taxes (Quarterly) stood at $960,000 in 2024, then skyrocketed by 95.12% to $960,000 in 2025.
  • Its Current Taxes stands at $960,000 for Q1 2025, versus $960,000 for Q4 2024 and $493,000 for Q3 2024.